newsfilter
← Latest News
GlobeNewswire·

Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference

HOUSTON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer and R